BRWM
ELOX

B. Riley Wealth Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

B. Riley Wealth Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$10 Hold
938
– – ﹤0.01% 752
2022
Q1 		$21K Sell
938
-275
-23% -$5.41K ﹤0.01% 621
2021
Q4 		$34K Buy
+1,213
New +$52.9K ﹤0.01% 649

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

B. Riley Wealth Management's ELOX Position: Q2 2022 in Review

B. Riley Wealth Management held its Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) position steady in Q2 2022 at 938 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #752.

B. Riley Wealth Management first reported a position in ELOX in Q4 2021 and has held it in 3 quarters since. The position peaked at $34K in Q4 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

  • B. Riley Wealth Management held 938 shares of Eloxx Pharmaceuticals, Inc. Common Stock worth $10 as of Q2 2022.
  • B. Riley Wealth Management left its Eloxx Pharmaceuticals, Inc. Common Stock share count unchanged in Q2 2022.
  • Eloxx Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #752 holding.
  • B. Riley Wealth Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and has held it in 3 quarters since.
  • B. Riley Wealth Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $34K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.